Furthermore, our experimental setup revealed two potential candidate proteins (Fbln5 and Cdh13), whose expressions were critically changed in cerebral arteries compared to systemic arteries at the early-onset of hypertension in the SHR. The gene discussed is FBLN5; the disease is hypertensive disorder.